Skip to main content
. Author manuscript; available in PMC: 2021 May 17.
Published in final edited form as: Arthritis Rheumatol. 2018 Mar 7;70(4):585–593. doi: 10.1002/art.40383

Table 1.

Baseline characteristics of CAMA study participants.

Serologically confirmed CHIKV arthritis cases
Characteristic No prior arthritis (n=25) Prior history of arthritis (n= 8) Controls (n= 10) p-value
Agea 56.0 (10.0) 59.6 (12.2) 31.7 (7.8) <0.0001
Body Mass Indexa 30.0 (4.5) 27.1 (5.8) 24.7 (5.3) 0.03
Female Genderb 20/25 (80%) 7/8 (88%) 7/10 (78%) 0.99
Afro-Colombian ethnicityb 13/25 (52%) 5/8 (63%) 5/10 (50%) 0.90
White-Colombian ethnicityb 8/25 (32%) 3/8 (38%) 4/10 (40%)
High school or less educational levelb 23/25 (92%) 8/8 (100%) 0 (0%) <0.0001
Presence of comorbiditiesb 9/25 (36%) 6/8 (75%) 0 (0%) 0.0025
>3 comorbiditiesb 0 1 (13%) 0 0.19
Comorbiditiesb
 Rheumatoid arthritis 0 1 (12.5%) 0 0.19
 Osteoarthritis 0 3 (37.5%) 0 0.0045
 Ischemic heart disease 0 0 0 NA
 Chronic kidney disease 0 0 0 NA
 Chronic pulmonary disease 0 0 0 NA
 Diabetes 1 (4.0%) 1 (12.5%) 0 0.39
 Hypertension 7 (28.0%) 4 (50.0%) 0 0.05
 Depression 1 (4.0%) 0 0 0.99
a

mean(sd)

b

n(%)